filmov
tv
The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL
Показать описание
Thomas Kipps, MD from the University of California, San Diego, CA, discussed the impact of the clinical trial of venetoclax (ABT-199) with obinutuzumab in the treatment landscape chronic lymphocytic leukemia (CLL).
0:02:09
0:04:13
0:03:33
0:02:23
0:04:33
0:04:10
0:11:14
0:01:51
0:50:38
0:09:49
0:01:35
0:16:25
0:02:30
0:10:59
0:03:03
0:59:50
0:12:50
0:42:00
0:53:27
0:01:18
0:02:51
0:01:26
0:13:37
0:29:41